| CASE REPORT |
|
| Year : 2021 | Volume
: 5
| Issue : 4 | Page : 168-170 |
|
|
Failure of therapeutic enoxaparin to prevent massive deep vein thrombosis and cerebral venous sinus thrombosis in a pregnant patient with combined factor v leiden mutation and antithrombin iii deficiency
Husam Nabil Abduljabbar Al-Dubai1, Yousef Mohammed Hailan1, Abdulrahman Al-Mashdali1, Akram Fadhl Mohammed Al-Warqi2, Bisher Sawaf1
1 Department of Internal Medicine, Hamad General Hospital, HMC, Doha, Qatar
2 Department of Radiology, Hamad General Hospital, HMC, Doha, Qatar
Correspondence Address:
Dr. Husam Nabil Abduljabbar Al-Dubai
P.O. Box: 3050, Doha
Qatar
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/ljms.ljms_59_21
|
|
|
Women with combined inherited thrombophilia are at high risk of developing thrombotic events, especially when they are pregnant. Low-molecular-weight (LMW) heparins are the preferable agents for anticoagulation during pregnancy. Despite the fact that they have been proven to be effective in the treatment and prevention of venous thromboembolism, thrombotic events can still happen. Here, we report a case of a 40-year-old white pregnant woman with combined factor V Leiden mutation and antithrombin III deficiency who developed massive deep vein thrombosis and cerebral venous sinus thrombosis despite being on therapeutic doses of enoxaparin.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
